Article feature image

Relmada Therapeutics, Inc. (RLMD) CEO Sergio Traversa on Q2 2021 Results – Earnings Call Transcript

Stock Analysis

Relmada Therapeutics, Inc. (RLMD) Q2 2021 Earnings Conference Call August 10, 2021 4:30 PM ET
Company Participants
Timothy McCarthy – LifeSci Advisors
Sergio Traversa – CEO & Director
Charles Ence – Chief Accounting & Compliance Officer
Charles Gorodetzky…

Click here to view the original article.

Tags:
,
Facebook Google+ Twitter Pinterest

Related Posts